Nuedexta (Dextromethorphan / Quinidine)

Nuedexta is a medicine used to treat pseudobulbar affect, a condition that causes sudden laughing or crying that doesn't match how a person feels. It is taken as a capsule by mouth. One ingredient calms certain brain signals, and the other helps the first one last longer in the body.

Brand names:Nuedexta
Medication

What people taking Nuedexta (Dextromethorphan / Quinidine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Nuedexta (Dextromethorphan / Quinidine) for Pseudobulbar Affect?

NameHow it went

About Nuedexta (Dextromethorphan / Quinidine)

What It's For

Nuedexta is a prescription capsule that combines two medicines, dextromethorphan and quinidine, to treat pseudobulbar affect (PBA). PBA causes sudden, frequent episodes of laughing or crying that a person cannot control and that don't match how they actually feel, or are far out of proportion to it. It develops as a result of neurological conditions such as ALS (amyotrophic lateral sclerosis), multiple sclerosis, stroke and traumatic brain injury. PBA is a specific condition, distinct from the other kinds of emotional ups and downs that can follow a neurological illness, so an accurate diagnosis comes before treatment. Dextromethorphan-quinidine is the only medicine approved by the FDA specifically for PBA, and generic capsules with the same ingredients are also available. It is used in adults; safety and effectiveness have not been established in anyone under 18.

How It Works

Dextromethorphan is best known as a cough suppressant in over-the-counter medicines. In the brain it acts on NMDA receptors, which respond to the signaling chemical glutamate, and on sigma-1 receptors, which help regulate nerve cell activity. Exactly how these actions reduce PBA episodes is not known. On its own, dextromethorphan is broken down quickly by a liver enzyme called CYP2D6. Quinidine, a drug better known as a heart rhythm medicine, blocks that enzyme, so dextromethorphan reaches higher and steadier levels in the blood. The amount of quinidine in Nuedexta is small: blood levels are only a few percent of those used to treat heart rhythm problems. Some people naturally have little or no CYP2D6 activity (called poor metabolizers). In them, quinidine adds nothing to the benefit but can still cause its side effects, so a genetic test is sometimes considered for people at particular risk from quinidine.

Dosage & Administration

Nuedexta comes as a single strength capsule containing 20 mg of dextromethorphan and 10 mg of quinidine. Treatment starts with one capsule a day for the first seven days, then continues as one capsule every 12 hours. It can be taken with or without food. No more than two capsules should be taken in 24 hours, and doses should be spaced about 12 hours apart. If a dose is missed, the next one is taken at the usual time rather than doubled. Nuedexta should not be shared, even with someone who has similar symptoms.

Side Effects

Diarrhea and dizziness are the most common side effects. In the main 12-week trial, diarrhea affected 13% of people taking Nuedexta compared with 6% on placebo, and dizziness 10% compared with 5%. Cough, vomiting, weakness, swelling in the legs or feet, urinary tract infections, flu-like illness and gas were also more common than with placebo. Dizziness matters most for people whose condition already affects walking or balance, since it adds to the risk of falls. Rarely, the quinidine component triggers an immune reaction that destroys platelets, the blood cells that help blood clot. This can be severe or fatal because it leads to bleeding. It may start with vague symptoms such as lightheadedness, chills, fever, nausea or vomiting, and can show up as unusual bruising or bleeding. Quinidine has also caused liver inflammation (hepatitis), usually in the first few weeks and often with fever. Contact the prescriber right away about any of these signs. The medicine is stopped if either problem is confirmed, and after a platelet reaction it should not be restarted. Signs of an allergic reaction, such as rash, hives or swelling, need prompt medical attention.

Interactions & Warnings

Nuedexta is not used by people with heart failure, a prolonged QT interval (a delay in the heart's electrical recharging between beats, seen on an ECG, or electrocardiogram), congenital long QT syndrome, a history of the dangerous rhythm called torsades de pointes, or complete heart block without a pacemaker. Because the medicine itself lengthens the QT interval, an ECG before starting and again 3 to 4 hours after the first dose is recommended for people at higher risk. That includes people with a thickened or weakened heart muscle, which is more likely after long-standing high blood pressure, coronary artery disease or stroke, and people taking other medicines that lengthen the QT interval or certain antibiotics, antifungals and HIV medicines that add to the risk. Low potassium or magnesium is corrected before treatment. Fainting, or a racing or pounding heartbeat, should be reported to the prescriber immediately. Some combinations are ruled out entirely: MAOIs (monoamine oxidase inhibitors, an older group of antidepressants) within 14 days before or after Nuedexta, because of serious and possibly fatal reactions; other products containing quinidine, quinine or mefloquine (a malaria medicine); and the antipsychotics thioridazine and pimozide. Taking it with SSRIs (selective serotonin reuptake inhibitors, a common group of antidepressants) such as fluoxetine, or with tricyclic antidepressants, raises the risk of serotonin syndrome, an excess of serotonin activity that can cause confusion, restlessness, fever, sweating, shivering, muscle jerks and tremor. Because quinidine blocks CYP2D6, it can raise the levels of other drugs that enzyme processes. Doses of the antidepressants desipramine and paroxetine may need lowering, and levels of digoxin, a heart medicine, can roughly double. It can also stop codeine and hydrocodone, opioid pain medicines that need CYP2D6 to become active, from working properly. Alcohol and other sedating medicines call for caution, and quinidine's effects can worsen myasthenia gravis. There are no adequate data on use in pregnancy, animal studies showed harm to developing offspring, and quinidine passes into breast milk, so pregnancy and breastfeeding plans belong in the conversation before starting.

What to Expect

Nuedexta is meant to make PBA episodes less frequent and less intense. It does not treat the underlying neurological disease. Its approval rests mainly on a 12-week trial in people with ALS or multiple sclerosis, in which laughing and crying episodes and scores on a PBA symptom questionnaire fell significantly more than with placebo. Experience in people whose PBA follows stroke, brain injury or other conditions is more limited. Keeping a simple record of how often episodes happen, before and during treatment, helps the prescriber judge whether it is working. Diarrhea and dizziness tend to show up early, so the first weeks are a good time to report problems. PBA improves on its own in some people, so the need to keep taking Nuedexta is reassessed from time to time. ECG checks may be repeated if heart risk factors or other medicines change, and every new prescriber and pharmacist should know it is being taken.

Questions to Ask Your Doctor

  1. 1.Are these episodes PBA, or could depression or another mood change be part of what I'm experiencing?
  2. 2.Given my heart history and other medicines, do I need an ECG or blood tests before starting?
  3. 3.Which of my current medicines, including antidepressants and pain medicines, could interact with Nuedexta?
  4. 4.How will we judge whether it is working, and when should we revisit whether I still need it?
  5. 5.Is a generic version an option for me, and is it covered by my insurance?

Last reviewed • Oct 2026

Educational content, not medical advice.